New clinical perspectives from nurses on aprotinin and fibrin sealants.
Zoegall
Stephen G
SG
D000707:Anaphylaxis / Q000139:chemically induced; D007611:Aprotinin / Q000008:administration & dosage / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000401:mortality / Q000451:nursing* / Q000601:surgery; D002986:Clinical Trials as Topic; D015718:Fibrin Tissue Adhesive / Q000008:administration & dosage / Q000009:adverse effects*; D006490:Hemostatics / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced; D009726:Nurses; D016032:Randomized Controlled Trials as Topic; D051437:Renal Insufficiency / Q000139:chemically induced; D020521:Stroke / Q000139:chemically induced
D015718:Fibrin Tissue Adhesive; D006490:Hemostatics; D007611:Aprotinin